| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |